Clinical Trial Update: The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of SHR4640 tablets in combination with febuxostat 40 mg for primary gout and hyperuricemia; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Primary Gout and Hyperuricemia | Phase 2 | Status: RECRUITING